TY - GEN 
AU - Esteban, Efraín
AU - Bustos, Rosa-Helena
AU - García, Julio-César
AU - Jáuregui, Edwin
PY - 2019
UR - http://hdl.handle.net/10818/56644
AB - Developing new biologics has led to regulations and norms aimed at guaranteeing their safety, quality and effectiveness, in terms of marketing, prescription, use, interchangeability and switching. Biologics are of great importance in treating patients...
AB - El desarrollo de nuevos biologicos ha dado lugar a regulaciones y normas destinadas a garantizar su seguridad, calidad y eficacia, en terminos de comercializacion, prescripcion, uso, intercambiabilidad y cambio. Los productos biologicos son de gran...
LA - eng
PB - Current Clinical Pharmacology,
KW - Biosimilar
KW - Biologico
KW - Medicamento biotecnologico
KW - Biofarmaceutico
KW - Anticuerpo monoclonal
KW - Citocinas
KW - Factores de coagulacion.
KW - Biosimilar
KW - Biologic
KW - Biotechnological drug
KW - Biopharmaceutical
KW - Monoclonal antibody
KW - Cytokines
KW - Coagulation factors.
TI - Biosimilars: An Approach to some Current Worldwide Regulation Frameworks
DO - 10.2174/1574884713666181025142928
ER -